Related Experiment Video
Updated: Jan 22, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor.
Eric M Green1, Reinier van Mourik2, Charles Wolfus1
1MyoKardia, Inc., South San Francisco, CA USA.
Smartwatches may soon screen for hypertrophic cardiomyopathy (HCM), a serious heart condition. Photoplethysmography analysis from watches identified obstructive HCM with high accuracy, aiding early diagnosis.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Diagnostics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease with significant risks, including heart failure and sudden death.
- Current diagnosis rates are low (10-20%), highlighting the need for accessible, non-clinical screening methods.
- Photoplethysmography (PPG) is a noninvasive optical technique measuring blood volume changes, commonly available in smartwatches.
Purpose of the Study:
- To evaluate the efficacy of PPG-based analysis for detecting obstructive HCM (oHCM).
- To develop and validate a machine learning classifier for oHCM screening using PPG data.
Main Methods:
- Collected PPG recordings and echocardiograms from 19 oHCM patients and 64 healthy controls.
- Utilized automated analysis to compare 42 morphometric pulse wave features between groups.
- Developed a machine learning classifier to distinguish oHCM from controls.
Main Results:
- Significant differences (38/42 features) were observed in pulse wave morphology between oHCM patients and controls.
- The machine learning classifier achieved a high C-statistic of 0.99 for oHCM detection.
- Key differentiating features included systolic ejection time, rate of rise, and respiratory variation.
Conclusions:
- PPG analysis combined with machine learning shows promise as a noninvasive screening tool for oHCM.
- This technology could significantly improve early detection rates for hypertrophic cardiomyopathy.
- Further development may lead to a widely accessible screening method for obstructive HCM via smartwatches.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care

